Literature DB >> 23199841

The association between obesity, mortality and filling pressures in pulmonary hypertension patients; the "obesity paradox".

Barak Zafrir1, Yochai Adir, Waseem Shehadeh, Michal Shteinberg, Nabia Salman, Offer Amir.   

Abstract

BACKGROUND: The term "obesity paradox", refers to lower mortality rates in obese patients, and is evident in various chronic cardiovascular disorders. There is however, only scarce data regarding the clinical implication of obesity and pulmonary hypertension (PH). Therefore, in the current study, we evaluated the possible prognostic implications of obesity in PH patients.
METHODS: We assessed 105 consecutive PH patients for clinical and hemodynamic parameters, focusing on the possible association between Body Mass Index (BMI) and mortality. Follow-up period was 19 ± 13 months.
RESULTS: Sixty-one patients (58%) had pre-capillary PH and 39 patients (37%) out-of-proportion post-capillary PH. During follow-up period, 30 patients (29%) died. Death was associated with reduced functional-class, inverse-relation with BMI, higher pulmonary artery and right atrial pressures, pulmonary vascular resistance and signs of right ventricular failure. In multivariate analysis, obesity (BMI ≥ 30 kg/m²), was the variable most significantly correlated with improved survival [H.R 0.2, 95% C.I 0.1-0.6; p = 0.004], even after adjustment for baseline characteristics. Obese and very-obese (BMI ≥ 35 kg/m²) patients had significantly less mortality rates during follow-up (12% and 8%, respectively) than non-obese patients (41%), p = 0.01. The tendency of survival benefit for the obese vs. non-obese patients was maintained both in the pre-capillary (10% vs. 46% mortality, p = 0.008) and disproportional post-capillary PH patients (11% vs. 40% mortality, p = 0.04).
CONCLUSIONS: Obesity was significantly associated with lower mortality in both pre-capillary and disproportional post-capillary PH patients. It seems that in PH, similarly to other chronic clinical cardiovascular disease states, there may be a protective effect of obesity, compatible with the "obesity paradox".
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23199841     DOI: 10.1016/j.rmed.2012.10.019

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  26 in total

1.  Survival protection by bodyweight in isolated scleroderma-related pulmonary artery hypertension.

Authors:  Carlo Marini; Bruno Formichi; Carolina Bauleo; Claudio Michelassi; Edoardo Airò; Giuseppe Rossi; Carlo Giuntini
Journal:  Intern Emerg Med       Date:  2016-04-06       Impact factor: 3.397

Review 2.  Pulmonary vascular dysfunction in metabolic syndrome.

Authors:  Conor Willson; Makiko Watanabe; Atsumi Tsuji-Hosokawa; Ayako Makino
Journal:  J Physiol       Date:  2018-09-12       Impact factor: 5.182

3.  Obesity paradox in group 1 pulmonary hypertension: analysis of the NIH-Pulmonary Hypertension registry.

Authors:  S Mazimba; E Holland; V Nagarajan; A D Mihalek; J L W Kennedy; K C Bilchick
Journal:  Int J Obes (Lond)       Date:  2017-02-17       Impact factor: 5.095

4.  Sympathetic hyper-excitation in obesity and pulmonary hypertension: physiological relevance to the 'obesity paradox'.

Authors:  C Diong; P P Jones; H Tsuchimochi; E A Gray; G Hughes; T Inagaki; C T Bussey; Y Fujii; K Umetani; M Shirai; D O Schwenke
Journal:  Int J Obes (Lond)       Date:  2016-02-23       Impact factor: 5.095

5.  Association between muscle mass and adipo-metabolic profile: a cross-sectional study in older subjects.

Authors:  Simone Perna; Davide Guido; Mario Grassi; Mariangela Rondanelli
Journal:  Clin Interv Aging       Date:  2015-02-26       Impact factor: 4.458

6.  Calorie Restriction Attenuates Monocrotaline-induced Pulmonary Arterial Hypertension in Rats.

Authors:  Mingge Ding; Jingyi Lei; Yinxian Qu; Huan Zhang; Weichuan Xin; Feng Ma; Shuwen Liu; Zhichao Li; Faguang Jin; Enqing Fu
Journal:  J Cardiovasc Pharmacol       Date:  2015-06       Impact factor: 3.105

7.  Paradoxical association between body mass index and in-hospital mortality in elderly patients with chronic obstructive pulmonary disease in Japan.

Authors:  Yasuhiro Yamauchi; Wakae Hasegawa; Hideo Yasunaga; Mitsuhiro Sunohara; Taisuke Jo; Kazutaka Takami; Hiroki Matsui; Kiyohide Fushimi; Takahide Nagase
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2014-12-09

8.  Obesity in Pulmonary Arterial Hypertension (PAH): The Pulmonary Hypertension Association Registry (PHAR).

Authors:  Jeff Min; Rui Feng; David Badesch; Erika Berman-Rosenzweig; Charles Burger; Murali Chakinala; Teresa De Marco; Jeremy Feldman; Anna Hemnes; Evelyn M Horn; Matthew R Lammi; Stephen Mathai; John W McConnell; Kenneth Presberg; Jeffrey Robinson; Jeffrey Sager; Oksana A Shlobin; Marc Simon; Thenappan Thenappan; Corey Ventetuolo; Nadine Al-Naamani
Journal:  Ann Am Thorac Soc       Date:  2020-10-21

9.  Risk Factors of Pulmonary Arterial Hypertension and Its Relationship With Atrial Fibrillation in Patients With Obstructive Hypertrophic Cardiomyopathy.

Authors:  Changrong Nie; Changsheng Zhu; Minghu Xiao; Zhengyang Lu; Qiulan Yang; Yanhai Meng; Rong Wu; Shuiyun Wang
Journal:  Front Cardiovasc Med       Date:  2021-07-07

10.  Outcomes of Idiopathic Pulmonary Fibrosis Improve with Obesity: A Rural Appalachian Experience.

Authors:  Rahul G Sangani; Andrew J Ghio; Hasan Mujahid; Zalak Patel; Kristen Catherman; Sijin Wen; John E Parker
Journal:  South Med J       Date:  2021-07       Impact factor: 0.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.